Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn's disease and ulcerative colitis - experiences from a single center
| Image |  |
|---|---|
| Description | scientific article published on 18 August 2017 |
| Author/s |
author: Tamás Molnár Renáta Bor Peter Laszlo Lakatos Anna Fábián Zoltán Szepes Anita Bálint Klaudia Farkas Ágnes Milassin Mariann Rutka Tamás Ferenci |
| Publication date | August 18, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |